Beer May Treat Diabetes and Provide Weight Loss: Time to Pour a Little Beer on Your Portfolio
In a recent article in ScienceDaily, it described how moderate beer consumption could have beneficial effects on diabetes, some forms of cancer, and may provide weight loss. The humulone molecules produced from hops in the brewing process are what provide the health benefits. Several pharmaceutical companies are researching was to convert these humulones to drugs to treat various illnesses.
Based on the free recently updated list at WallStreetNewsNetwork.com, there are over dozen publicly traded breweries and beer retailers. Plus, half a dozen of the beer stocks pay dividends, ranging from 1% to 2.8%.
One example is Heineken NV (HEINY), which trades at 11 times earnings and yields 1.5%. Management of Heineken must have a sense of humor since the company's previous stock ticker symbol used to be HINKY, and now it is HEINY.
Anheuser-Busch InBev (BUD), has the famous stock symbol representing its popular Budweiser brand. It also sells Stella Artois, Beck's, Leffe, Bud Light, Skol, Brahma, Quilmes, Michelob, and many other brands. The stock has a current price to earnings ratio of 21, and stock sports a yield of 1.4%.
Another dividend paying brewery is Molson Coors Brewing Company (TAP), a Canadian based company that markets the Coors Light, Molson, Carling, Pilsner, Keystone Light, and Granville Island brands. The stock trades at 19 times current earnings and yields 2.8%.
Compania Cerveceras Unidas S.A. (CCU), based in Santiago, Chile, makes and markets beer, wine, and other beverages throughout the countries of Chile and Argentina. Its brands includes Royal Guard; Royal Light; Heineken; Budweiser; and Paulaner. It trades at 21 times current earnings, 14.1 times future earnings, and pays a dividend yield of 1.0%.
If you are looking for more beer stocks , check out the free list at WallStreetNewsNetwork.com, which can be updated, sorted, and downloaded.
Disclosure: Author did not own any of the above at the time the article was written.
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.